ALPS Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Buy |
17,462
+15,542
| +809% | +$2.14M | 0.01% | 339 |
|
|
2025
Q1 | $346K | Buy |
+1,920
| New | +$346K | ﹤0.01% | 812 |
|
|
2024
Q4 | – | Sell |
-22,372
| Closed | -$4.07M | – | 1022 |
|
|
2024
Q3 | $4.07M | Buy |
22,372
+102
| +0.5% | +$18.6K | 0.03% | 258 |
|
|
2024
Q2 | $4.09M | Buy |
+22,270
| New | +$4.09M | 0.03% | 248 |
|
|
2023
Q4 | – | Sell |
-20,620
| Closed | -$2.39M | – | 994 |
|
|
2023
Q3 | $2.39M | Buy |
20,620
+384
| +2% | +$44.5K | 0.02% | 299 |
|
|
2023
Q2 | $2.38M | Buy |
20,236
+3,259
| +19% | +$383K | 0.02% | 282 |
|
|
2023
Q1 | $1.36M | Sell |
16,977
-467
| -3% | -$37.4K | 0.01% | 381 |
|
|
2022
Q4 | $1.38M | Buy |
17,444
+3,403
| +24% | +$270K | 0.01% | 378 |
|
|
2022
Q3 | $979K | Sell |
14,041
-1,170
| -8% | -$81.6K | 0.01% | 473 |
|
|
2022
Q2 | $999K | Sell |
15,211
-10,702
| -41% | -$703K | 0.01% | 476 |
|
|
2022
Q1 | $1.72M | Sell |
25,913
-2,906
| -10% | -$193K | 0.02% | 246 |
|
|
2021
Q4 | $2.02M | Buy |
28,819
+1,606
| +6% | +$112K | 0.02% | 288 |
|
|
2021
Q3 | $1.42M | Sell |
27,213
-2,028
| -7% | -$106K | 0.01% | 355 |
|
|
2021
Q2 | $1.99M | Sell |
29,241
-6,413
| -18% | -$436K | 0.02% | 330 |
|
|
2021
Q1 | $2.75M | Buy |
35,654
+111
| +0.3% | +$8.55K | 0.03% | 226 |
|
|
2020
Q4 | $2.13M | Buy |
35,543
+10,467
| +42% | +$628K | 0.02% | 260 |
|
|
2020
Q3 | $1.08M | Buy |
25,076
+1,357
| +6% | +$58.4K | 0.02% | 346 |
|
|
2020
Q2 | $982K | Sell |
23,719
-7,751
| -25% | -$321K | 0.01% | 316 |
|
|
2020
Q1 | $1.36M | Sell |
31,470
-3,366
| -10% | -$146K | 0.02% | 242 |
|
|
2019
Q4 | $1.93M | Buy |
34,836
+348
| +1% | +$19.3K | 0.02% | 230 |
|
|
2019
Q3 | $1.2M | Buy |
34,488
+4,260
| +14% | +$148K | 0.01% | 273 |
|
|
2019
Q2 | $1.22M | Sell |
30,228
-4,623
| -13% | -$186K | 0.01% | 286 |
|
|
2019
Q1 | $1.15M | Buy |
34,851
+1,507
| +5% | +$49.6K | 0.01% | 297 |
|
|
2018
Q4 | $693K | Buy |
+33,344
| New | +$693K | 0.01% | 396 |
|